EN
HI
Parmax Pharma Chart
Parmax Pharma Share Key Metrics
Volume
1165.00
Market Cap
19.17 CR
LTQ@LTP
30@53.81
ATP
53.81
Var Margin
100 %
Circuit Range
48.69-53.81
Delivery %
100 %
Value
62688.65
ASM/GSM
No
Market Lot
1
Summary
Parmax Pharma share price is ₹53.81 as of 10 Jun, 2026. The stock Parmax Pharma intraday movement has stayed between ₹53.81 and ₹53.81, while on a 52-week basis,Parmax Pharma price 52 week high is ₹53.81 & its 52 week low is ₹22.60.
In terms of trading activity, Parmax Pharma has recorded a volume of 1165 shares, The Parmax Pharma has a market cap of ₹3741300 CR. The stock’s Average Traded Price (ATP) stands at ₹53.81, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 30 @ ₹53.81.
Parmax Pharma operates within a circuit range of ₹48.69 – ₹53.81, with a Value of ₹62688.65. The Delivery Percentage for the day is 100%. Additionally, Parmax Pharma currently falls under the No framework, and trades with a market lot size of 1.
Parmax Pharma Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
70.43
Sector P/B
3.01
Sec. Div. Yield
0.54
Parmax Pharma Resistance and Support
Pivot 51.09
Resistance
First Resistance
51.42
Second Resistance
51.58
Third Resistance
51.91
Support
First Support
50.93
Second Support
50.6
Third Support
50.44
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-06-08 | Fund raising |
| 2026-06-02 | Audited Results |
| 2026-05-30 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Parmax Pharma News
Parmax Pharma Ltd - 540359 - EGM Scheduled To Be Held On July 02, 2026
Parmax Pharma is seeking shareholder approval to raise ₹19.28 crore through a preferential issue of 3.13 million equity shares and 2.14 million convertible warrants at ₹36.50 each. This fundraise will lead to a change in promoter control and trigger a mandatory open offer.
Jun 09 2026 23:02:55
Parmax Pharma Ltd - 540359 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
A new investor group is set to acquire majority control of Parmax Pharma through a combination of a Share Purchase Agreement and a preferential allotment totaling Rs.19.28 crore. The board will be reconstituted post-transaction.
Jun 09 2026 22:51:40
Read More
Parmax Pharma Management
| Name | Position |
|---|---|
| Umang A Gosalia | Managing Director |
| Nikhil Uchat | Non Executive Independent Director |
Parmax Pharma Similar Stocks
Beryl Drugs Ltd.
24.25
0.00 (0.00%)
Sharma East India Hospitals & Medical Research Ltd
106.70
-1.20 (1.11%)
Starsource Multitrade Ltd.
118.95
5.00 (4.39%)
Norris Medicines Ltd.
14.00
-0.18 (1.27%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Colinz Laboratories Ltd.
55.90
-2.92 (4.96%)
Broach Lifecare Hospital Ltd.
16.99
0.00 (0.00%)
Unjha Formulations Ltd.
19.20
-0.75 (3.76%)
Kobo Biotech Ltd.
5.76
0.27 (4.92%)
Dolphin Medical Services Ltd.
7.89
0.00 (0.00%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 53.81 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 70.43 & 3.01 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 19.17 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 53.81 & 22.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
